Enovis (ENOV) Other Non-Current Assets (2010 - 2026)
Enovis (ENOV) reported Other Non-Current Assets of $94.0 million for Q2 2026, up 8.33% year-over-year from $86.7 million in Q2 2025, and up 0.66% quarter-over-quarter from $93.3 million in Q4 2025.
Enovis (ENOV) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Enovis (ENOV) has 17 years of Other Non-Current Assets data on file, last reported at $94.0 million in Q2 2026.
- Other Non-Current Assets for Q2 2026 came in at $94.0 million, up 8.33% year-over-year; the trailing twelve-month figure through Apr 2026 was $94.0 million (up 8.33% YoY), and the FY2025 annual result was $93.3 million, up 5.15% from the prior year.
- Other Non-Current Assets improved to $94.0 million in Q2 2026 per ENOV's latest filing, from $93.3 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $374.8 million in Q2 2022 and troughed at $43.3 million in Q4 2025.
- A 5-year average of $105.6 million and a median of $89.2 million in 2024 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets tumbled 97.07% in 2022, then rose 12.41% in 2023.
- A 5-year view of Other Non-Current Assets shows it stood at $80.3 million in 2022, then climbed by 12.41% to $90.3 million in 2023, then declined by 1.64% to $88.8 million in 2024, then advanced by 5.15% to $93.3 million in 2025, then increased by 0.66% to $94.0 million in 2026.
- Business Quant data shows ENOV's Other Non-Current Assets at $94.0 million in Q2 2026, $93.3 million in Q4 2025, and $43.3 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 828.89 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 285.90 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 211.40 Mn |
| 10 | Enovis | 1.26 Bn | 1.23 Bn | 365.49 Mn | 93.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 93.96 Mn |
| Dec 31, 2025 | 93.35 Mn |
| Oct 3, 2025 | 43.26 Mn |
| Jul 4, 2025 | 92.41 Mn |
| Apr 4, 2025 | 86.74 Mn |
| Dec 31, 2024 | 88.78 Mn |
| Sep 27, 2024 | 90.32 Mn |
| Jun 28, 2024 | 88.65 Mn |
| Mar 29, 2024 | 89.19 Mn |
| Dec 31, 2023 | 90.26 Mn |
| Sep 29, 2023 | 94.94 Mn |
| Jun 30, 2023 | 88.78 Mn |
| Mar 31, 2023 | 87.87 Mn |
| Dec 31, 2022 | 80.29 Mn |
| Apr 1, 2022 | 374.82 Mn |
| Dec 31, 2021 | 2.74 Bn |
| Oct 1, 2021 | 352.37 Mn |
| Jul 2, 2021 | 360.18 Mn |
| Apr 2, 2021 | 354.30 Mn |
| Dec 31, 2020 | 350.83 Mn |